| P50 | author | Anita Slade | Q46311940 |
| | Derek Kyte | Q56433248 |
| | Christel McMullan | Q56571016 |
| | Olalekan Lee Aiyegbusi | Q57003913 |
| P2093 | author name string | Melanie J Calvert | |
| | Samantha Cruz Rivera | |
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| | Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making | Q26852751 |
| | The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials | Q27009483 |
| | Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making | Q28087212 |
| | Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance | Q29615569 |
| | Three approaches to qualitative content analysis | Q29619566 |
| | Describing the impact of health research: a Research Impact Framework | Q30398784 |
| | What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability | Q30490684 |
| | Clinical Trial Patient-reported Outcomes Data: Going Beyond the Label in Oncology. | Q31066748 |
| | 'Trial Exegesis': Methods for Synthesizing Clinical and Patient Reported Outcome (PRO) Data in Trials to Inform Clinical Practice. A Systematic Review | Q31125157 |
| | Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards | Q31138363 |
| | The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. | Q33313280 |
| | Beyond citation analysis: a model for assessment of research impact | Q33526267 |
| | How can payback from health services research be assessed? | Q33581985 |
| | Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers | Q33652833 |
| | The COMET Handbook: version 1.0. | Q33877196 |
| | Patient reported outcomes: looking beyond the label claim | Q34114747 |
| | Recommendations on health-related quality of life research to support labeling and promotional claims in the United States | Q34205886 |
| | Measuring the impact of methodological research: a framework and methods to identify evidence of impact | Q34650692 |
| | The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review | Q34795994 |
| | Does health intervention research have real world policy and practice impacts: testing a new impact assessment tool. | Q34940074 |
| | Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock | Q35068200 |
| | The FDA guidance for industry on PROs: the point of view of a pharmaceutical company | Q35129599 |
| | Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials | Q35186787 |
| | Impact of quality of life measurement in daily clinical practice | Q35914746 |
| | Implementing research results in clinical practice- the experiences of healthcare professionals. | Q35918666 |
| | The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? | Q35967646 |
| | Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. | Q36287102 |
| | Contribution mapping: a method for mapping the contribution of research to enhance its impact. | Q36298815 |
| | Quality of life assessment in surgical oncology trials | Q36516491 |
| | Health-related quality of life measurement in randomized clinical trials in surgical oncology | Q36523679 |
| | Measuring the impact of medical research: moving from outputs to outcomes | Q36724442 |
| | Patient-reported outcomes to support medical product labeling claims: FDA perspective | Q36997907 |
| | Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials | Q37008552 |
| | Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making | Q37191785 |
| | Health-related quality-of-life assessment in GI cancer randomized trials: improving the impact on clinical practice | Q37639326 |
| | Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. | Q37729195 |
| | Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers | Q37812571 |
| | Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009). | Q37827010 |
| | 'Making evidence count': a framework to monitor the impact of health services research. | Q37995708 |
| | Reasons for rejection of patient-reported outcome label claims: a compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006-2010. | Q38009924 |
| | Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer | Q38053978 |
| | Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making | Q38211577 |
| | The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review | Q38230773 |
| | Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review: Perspectives From Industry, the Food and Drug Administration, and the Patient | Q38548372 |
| | Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting. | Q38611370 |
| | Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation | Q38724806 |
| | Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014). | Q38805911 |
| | Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making? | Q40562533 |
| | Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013). | Q41036982 |
| | Assessing the impact of healthcare research: A systematic review of methodological frameworks. | Q41326448 |
| | The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice | Q42862858 |
| | Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists' perspectives | Q44542767 |
| | Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension | Q48504041 |
| | Reporting quality of life in clinical trials: a CONSORT extension | Q48547547 |
| | Assessing the quality and value of quality-of-life measurement in breast cancer clinical trials | Q48712506 |
| | Assessing the impact of health technology assessment | Q50189020 |
| | Patient Reported Outcomes (PROs) as Part of Value-Based Care Can Shape Therapy Guidelines: Impact on Emerging Targeted Agents and Immunotherapy Protocols in Resource-Limited Regions. | Q53711726 |
| | Measuring the impact of health research | Q56903632 |
| | The importance of patient-reported outcomes in clinical trials and strategies for future optimization | Q59135171 |
| | Integrating patient-reported outcomes in healthcare policy, research and practice | Q84751861 |
| | The Use of Patient-reported Outcomes in Demonstrating Safety and Efficacy in Oncology | Q89108296 |
| | Maximising the impact of patient reported outcome assessment for patients and society | Q91209327 |
| | Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials | Q92932859 |
| P433 | issue | 1 | |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 156 | |
| P577 | publication date | 2019-10-16 | |
| P1433 | published in | Health and Quality of Life Outcomes | Q15757755 |
| P1476 | title | The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | |
| P478 | volume | 17 | |